Evidence for the continued transmission of parvovirus <scp>B</scp>19 in patients with bleeding disorders treated with plasma‐derived factor concentrates
Evidence for the continued transmission of parvovirus <scp>B</scp>19 in patients with bleeding disorders treated with plasma‐derived factor concentrates is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Evidence for the continued transmission of parvovirus <scp>B</scp>19 in patients with bleeding disorders treated with plasma‐derived factor concentrates have?
Evidence for the continued transmission of parvovirus <scp>B</scp>19 in patients with bleeding disorders treated with plasma‐derived factor concentrates has 8 citations in the OpenAlex counts ScholarIQ stores.
When was Evidence for the continued transmission of parvovirus <scp>B</scp>19 in patients with bleeding disorders treated with plasma‐derived factor concentrates published?
Evidence for the continued transmission of parvovirus <scp>B</scp>19 in patients with bleeding disorders treated with plasma‐derived factor concentrates has 2013 year in the ScholarIQ index.
What is the open-access status of Evidence for the continued transmission of parvovirus <scp>B</scp>19 in patients with bleeding disorders treated with plasma‐derived factor concentrates?
Evidence for the continued transmission of parvovirus <scp>B</scp>19 in patients with bleeding disorders treated with plasma‐derived factor concentrates has closed oa status in the ScholarIQ index.
What is the DOI of Evidence for the continued transmission of parvovirus <scp>B</scp>19 in patients with bleeding disorders treated with plasma‐derived factor concentrates?
The DOI for Evidence for the continued transmission of parvovirus <scp>B</scp>19 in patients with bleeding disorders treated with plasma‐derived factor concentrates is on the source record.
What is the PMID of Evidence for the continued transmission of parvovirus <scp>B</scp>19 in patients with bleeding disorders treated with plasma‐derived factor concentrates?
The PMID for Evidence for the continued transmission of parvovirus <scp>B</scp>19 in patients with bleeding disorders treated with plasma‐derived factor concentrates is on the source record.
What is the OpenAlex record for Evidence for the continued transmission of parvovirus <scp>B</scp>19 in patients with bleeding disorders treated with plasma‐derived factor concentrates?
The OpenAlex for Evidence for the continued transmission of parvovirus <scp>B</scp>19 in patients with bleeding disorders treated with plasma‐derived factor concentrates is on the source record.